Read More 1 minute read Clinical News News DeepCure Selects First AI-Generated Drug Candidate, DC-9476, for Clinical Trials Key Highlights DeepCure selects DC-9476, a novel BRD inhibitor, as its first development candidate. DC-9476 targets multiple autoimmune… byChris-Anne RoqueAugust 15, 2024